In this article, Sian Gill, managing partner at leading full-service IP firm Venner Shipley, explores the acceleration of the global pharmaceuticals sector and explains why protecting IP is essential to maximising its long-term growth.
In this article, Sian Gill, managing partner at leading full-service IP firm Venner Shipley, explores the acceleration of the global pharmaceuticals sector and explains why protecting IP is essential to maximising its long-term growth.
Venner Shipley
The week's biggest stories from this industry, direct to your inbox.
